Pomerantz Investigates Claims on Behalf of Cellebrite DI Ltd. Investors

Law firm Pomerantz LLP is investigating claims on behalf of investors in Cellebrite DI Ltd. (NASDAQ: CLBT). The investigation focuses on whether Cellebrite and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

The inquiry follows Cellebrite's financial results announcement on August 13, 2026, for the second quarter. The company disclosed that its Annual Recurring Revenue (ARR) missed the low end of its prior guidance. Additionally, Cellebrite lowered its full-year ARR guidance and announced the sudden replacement of CEO Tom Hogan.

Following this news, Cellebrite's stock price fell by $4.45 per share, or 29.18%, closing at $10.80 per share on August 13, 2026. Investors who have incurred losses are advised to contact Pomerantz LLP for further information regarding potential class action participation.

Pomerantz LLP is a prominent firm known for its work in corporate, securities, and antitrust class litigation. The firm has a history of recovering substantial damages for investors in cases involving corporate misconduct and securities fraud.